|
GENERAL (Details Narrative) (USD $)
In Thousands, unless otherwise specified |
3 Months Ended | |
|---|---|---|
|
Mar. 31, 2015
|
Mar. 31, 2014
|
|
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
| Net loss | $ 630us-gaap_NetIncomeLoss | $ 503us-gaap_NetIncomeLoss |
| Net cash used in operating activities | $ 299us-gaap_NetCashProvidedByUsedInOperatingActivities | $ 157us-gaap_NetCashProvidedByUsedInOperatingActivities |
| Operation commenced date | Oct. 20, 2003 | |
| Description of company | The Company's principal research and development activities are conducted in Israel through its wholly-owned subsidiary, Nano Vibronix (Israel 2003) Ltd., a company registered in Israel, which commenced operations in October 2003. | |
| X | ||||||||||
|
- Definition
Description of activities of the registrant. No definition available.
|
| X | ||||||||||
|
- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Date the operations of the entity commenced, in CCYY-MM-DD format. No definition available.
|
| X | ||||||||||
|
- Details
|